Found: 68
Select item for more details and to access through your institution.
Possible zoonotic transmission of hepatitis E from pet pig to its owner.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Impact of direct‐acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 4, p. 486, doi. 10.1002/pds.5576
- By:
- Publication type:
- Article
Markers of Inflammation and Fibrosis in Alcoholic Hepatitis and Viral Hepatitis C.
- Published in:
- International Journal of Hepatology, 2012, p. 1, doi. 10.1155/2012/231210
- By:
- Publication type:
- Article
Sofosbuvir, velpatasvir and voxilaprevir: a new triple combination for hepatitis C virus treatment. One pill fits all? Is it the end of the road?
- Published in:
- Therapeutic Advances in Gastroenterology, 2018, v. 11, p. 1, doi. 10.1177/1756284818812358
- By:
- Publication type:
- Article
Hepatitis C in Patients With Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes.
- Published in:
- Clinical Infectious Diseases, 2018, v. 66, n. 11, p. 1742, doi. 10.1093/cid/cix1106
- By:
- Publication type:
- Article
Direct, indirect and total effect of HIV coinfection on the risk of non‐liver‐related cancer in hepatitis C virus‐infected patients treated by direct‐acting antivirals: a mediation analysis.
- Published in:
- HIV Medicine, 2021, v. 22, n. 10, p. 924, doi. 10.1111/hiv.13153
- By:
- Publication type:
- Article
Health-Related Quality of Life in Chronic HCV-Infected Patients Switching to Pegylated-Interferon-Free Regimens (ANRS CO20 CUPIC Cohort Study and SIRIUS Trial).
- Published in:
- Patient, 2017, v. 10, n. 5, p. 605, doi. 10.1007/s40271-017-0232-1
- By:
- Publication type:
- Article
Prospective screening of liver fibrosis in a primary care cohort using systematic calculation of fib-4 in routine results.
- Published in:
- PLoS ONE, 2021, v. 16, n. 7, p. 1, doi. 10.1371/journal.pone.0254939
- By:
- Publication type:
- Article
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis.
- Published in:
- BMC Infectious Diseases, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12879-022-07076-0
- By:
- Publication type:
- Article
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis.
- Published in:
- BMC Infectious Diseases, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12879-022-07076-0
- By:
- Publication type:
- Article
Real‐world economic burden of hepatitis C and impact of direct‐acting antivirals in France: A nationwide claims data analysis.
- Published in:
- Liver International, 2024, v. 44, n. 5, p. 1233, doi. 10.1111/liv.15872
- By:
- Publication type:
- Article
Late presentation for HCV care: Time to target people with diabetes and/or hazardous alcohol use (ANRS CO22 HEPATHER cohort).
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 38, doi. 10.1111/liv.15056
- By:
- Publication type:
- Article
Effectiveness of direct‐acting antivirals for chronic hepatitis C treatment in migrant and non‐migrant populations in France.
- Published in:
- Liver International, 2021, v. 41, n. 10, p. 2328, doi. 10.1111/liv.14823
- By:
- Publication type:
- Article
Prognostication of HCC under sorafenib: Is it always possible?
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1241, doi. 10.1111/liv.14294
- By:
- Publication type:
- Article
Abstracts.
- Published in:
- Liver International, 2019, v. 39, n. 12, p. 2420, doi. 10.1111/liv.14255
- By:
- Publication type:
- Article
Prognostic factors of survival in HIV/HCV co‐infected patients with hepatocellular carcinoma: The CARCINOVIC Cohort.
- Published in:
- Liver International, 2019, v. 39, n. 1, p. 136, doi. 10.1111/liv.13921
- By:
- Publication type:
- Article
Viral eradication is required for sustained improvement of patient‐reported outcomes in patients with hepatitis C.
- Published in:
- Liver International, 2019, v. 39, n. 1, p. 54, doi. 10.1111/liv.13900
- By:
- Publication type:
- Article
Prediction of benefit after transarterial chemoembolization (TACE): Subclassifications or scoring systems?
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Intermediate stage treatment: Is TACE enough?
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme.
- Published in:
- Liver International, 2017, v. 37, n. 9, p. 1314, doi. 10.1111/liv.13383
- By:
- Publication type:
- Article
HCC classification and HCC scoring system: a win-win combination for prognosis and treatment recommendations.
- Published in:
- Liver International, 2016, v. 36, n. 12, p. 1876, doi. 10.1111/liv.13140
- By:
- Publication type:
- Article
Nomogram of the Barcelona Clinic Liver Cancer System: external validation in European patients.
- Published in:
- Liver International, 2016, v. 36, n. 11, p. 1716, doi. 10.1111/liv.13171
- By:
- Publication type:
- Article
Staging of hepatocellular carcinoma: BCLC system, what else!
- Published in:
- Liver International, 2016, v. 36, n. 9, p. 1395, doi. 10.1111/liv.13066
- By:
- Publication type:
- Article
Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways.
- Published in:
- Advances in Therapy, 2021, v. 38, n. 3, p. 1397, doi. 10.1007/s12325-021-01636-7
- By:
- Publication type:
- Article
New anti HCV drugs in the pipeline.
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Minimal clinically important differences in health-related quality of life after treatment with direct-acting antivirals for chronic hepatitis C: ANRS CO22 HEPATHER cohort (PROQOL-HCV).
- Published in:
- Quality of Life Research, 2024, v. 33, n. 6, p. 1527, doi. 10.1007/s11136-024-03622-2
- By:
- Publication type:
- Article
Impaired health-related quality of life in the HCV cure era: who is concerned? (ANRS CO22 HEPATHER French cohort).
- Published in:
- Quality of Life Research, 2023, v. 32, n. 12, p. 3427, doi. 10.1007/s11136-023-03496-w
- By:
- Publication type:
- Article
Performance of algorithms for identifying patients with chronic hepatitis B or C infection in the french health insurance claims databases using the ANRS CO22 HEPATHER cohort.
- Published in:
- Journal of Viral Hepatitis, 2023, v. 30, n. 3, p. 232, doi. 10.1111/jvh.13788
- By:
- Publication type:
- Article
Cannabis use is associated with a lower risk of diabetes in chronic hepatitis C‐infected patients (ANRS CO22 Hepather cohort).
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 12, p. 1473, doi. 10.1111/jvh.13380
- By:
- Publication type:
- Article
Sofosbuvir and risk of estimated glomerular filtration rate decline or end‐stage renal disease in patients with renal impairment.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 9, p. 1169, doi. 10.1111/apt.16830
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Hepatitis C virus cure from direct‐acting antivirals and mortality: Are people with and without a history of injection drug use in the same boat? (ANRS CO22 Hepather cohort).
- Published in:
- Drug & Alcohol Review, 2024, v. 43, n. 3, p. 718, doi. 10.1111/dar.13802
- By:
- Publication type:
- Article
Independent Prospective Multicenter Validation of Biochemical Markers (Fibrotest–Actitest) for the Prediction of Liver Fibrosis and Activity in Patients with Chronic Hepatitis C: The Fibropaca Study.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2006, v. 101, n. 3, p. 547, doi. 10.1111/j.1572-0241.2006.00411.x
- By:
- Publication type:
- Article
Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus.
- Published in:
- Comparative Hepatology, 2005, v. 4, p. 6, doi. 10.1186/1476-5926-4-6
- By:
- Publication type:
- Article
Dried Blood Spot Sampling for Hepatitis B Virus Serology and Molecular Testing.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0061077
- By:
- Publication type:
- Article
Longitudinal Liver Stiffness Assessment in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0047715
- By:
- Publication type:
- Article
Detection of IL28B SNP DNA from Buccal Epithelial Cells, Small Amounts of Serum, and Dried Blood Spots.
- Published in:
- PLoS ONE, 2012, v. 7, n. 3, p. 1, doi. 10.1371/journal.pone.0033000
- By:
- Publication type:
- Article
NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging.
- Published in:
- Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 12, p. 2179, doi. 10.1111/jgh.14705
- By:
- Publication type:
- Article
Changes in liver stiffness measurements and fibrosis scores following sofosbuvir based treatment regimens without interferon.
- Published in:
- Journal of Gastroenterology & Hepatology, 2017, v. 32, n. 9, p. 1624, doi. 10.1111/jgh.13758
- By:
- Publication type:
- Article
Interferon-gamma with peginterferon alpha-2a and ribavirin in nonresponder patients with chronic hepatitis C ( ANRS HC16 GAMMATRI).
- Published in:
- Journal of Gastroenterology & Hepatology, 2013, v. 28, n. 2, p. 329, doi. 10.1111/jgh.12060
- By:
- Publication type:
- Article
Primary biliary cirrhosis–autoimmune hepatitis overlap syndrome: Complete biochemical and histological response to therapy with ursodesoxycholic acid.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Treatment With Ledipasvir-Sofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection: A Randomized Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Les points-clés à retenir/avis d'experts : du dépistage au traitement de l'hépatite chronique à virus Delta.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2022, v. 29, p. 45, doi. 10.1684/hpg.2022.2349
- By:
- Publication type:
- Article
Devant les avancées thérapeutiques majeures pour les cancers primitifs du foie, comment optimiser la prise en charge sur l'ensemble du territoire : un nouveau défi pour la spécialité.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2022, v. 29, n. 6, p. 679, doi. 10.1684/hpg.2022.2397
- By:
- Publication type:
- Article
2020, l'année de tous les virus.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Propositions de prise en charge des patients atteints de maladie du foie à l'occasion de la pandémie de Coronavirus 2019.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2020, v. 27, n. 5, p. 490, doi. 10.1684/hpg.2020.1974
- By:
- Publication type:
- Article
Meta-analyses of FibroTest diagnostic value in chronic liver disease.
- Published in:
- BMC Gastroenterology, 2007, v. 7, p. 40, doi. 10.1186/1471-230X-7-40
- By:
- Publication type:
- Article
Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2016, v. 15, n. 3, p. 333, doi. 10.5604/16652681.1198803
- By:
- Publication type:
- Article
The impact of ledipasvir/sofosbuvir on patient-reported outcomes in cirrhotic patients with chronic hepatitis C: the SIRIUS study.
- Published in:
- Liver International, 2016, v. 36, n. 1, p. 42, doi. 10.1111/liv.12886
- By:
- Publication type:
- Article
Prevalence of renal abnormalities in chronic HBV infection: The HARPE study.
- Published in:
- Liver International, 2015, v. 35, n. 1, p. 148, doi. 10.1111/liv.12480
- By:
- Publication type:
- Article